CT-Based Radiomics Nomogram for Prediction of Progression-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma

References

• ChenYP, ChanATC, LeQT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-031178151
   PubMed Web of Science ®Google Scholar
• LeeHM, OkudaKS, GonzálezFE, et al. Current perspectives on nasopharyngeal carcinoma. Adv Exp Med Biol. 2019;1164:11–34.31576537
   PubMed Web of Science ®Google Scholar
• SunXS, LiXY, ChenQY, et al. Future of radiotherapy in nasopharyngeal carcinoma. Br J Radiol. 2019;92(1102):20190209. doi:10.1259/bjr.2019020931265322
   PubMed Web of Science ®Google Scholar
• LeeAW, TungSY, ChuaDT, et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 2010;102(15):1188–1198. doi:10.1093/jnci/djq25820634482
   PubMed Web of Science ®Google Scholar
• MayerhoeferME, MaterkaA, LangsG, et al. Introduction to radiomics. J Nucl Med. 2020;61(4):488–495. doi:10.2967/jnumed.118.22289332060219
   PubMed Web of Science ®Google Scholar
• OuyangFS, GuoBL, ZhangB, et al. Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma. Oncotarget. 2017;8(43):74869–74879. doi:10.18632/oncotarget.2042329088830
   PubMedGoogle Scholar
• ZhaoL, GongJ, XiY, et al. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma. Eur Radiol. 2020;30(1):537–546. doi:10.1007/s00330-019-06211-x31372781
   PubMed Web of Science ®Google Scholar
• YangK, TianJ, ZhangB, et al. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma. Oral Oncol. 2019;98:85–91. doi:10.1016/j.oraloncology.2019.09.02231569054
   PubMed Web of Science ®Google Scholar
• PengH, DongD, FangMJ, et al. Prognostic value of deep learning PET/CT-based radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma. Clin Cancer Res. 2019;25(14):4271–4279. doi:10.1158/1078-0432.CCR-18-306530975664
   PubMed Web of Science ®Google Scholar
• LiangZG, TanHQ, ZhangF, et al. Comparison of radiomics tools for image analyses and clinical prediction in nasopharyngeal carcinoma. Br J Radiol. 2019;92(1102):20190271. doi:10.1259/bjr.2019027131453720
   PubMed Web of Science ®Google Scholar
• TengxiangL, GuanzhongG, QingtaoQ, et al. Quantitative analysis of CT radiomics features of nasopharyngeal carcinoma. Chinese J Med Phys. 2019;36(05):551–555.
   Google Scholar
• van TimmerenJE, CesterD, Tanadini-LangS, et al. Radiomics in medical imaging-”how-to” guide and critical reflection. Insights Imaging. 2020;11(1):91. doi:10.1186/s13244-020-00887-232785796
   PubMed Web of Science ®Google Scholar
• LambinP, Rios-VelazquezE, LeijenaarR, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–446. doi:10.1016/j.ejca.2011.11.03622257792
   PubMed Web of Science ®Google Scholar
• GohV, SangheraB, WellstedDM, et al. Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis. Eur Radiol. 2009;19(6):1358–1365. doi:10.1007/s00330-009-1304-y19190914
   PubMed Web of Science ®Google Scholar
• SkogenK, GaneshanB, GoodC, et al. Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade. J Neurooncol. 2013;111(2):213–219. doi:10.1007/s11060-012-1010-523224678
   PubMed Web of Science ®Google Scholar
• MaoYP, TangLL, ChenL, et al. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy. Chin J Cancer. 2016;35(1):103. doi:10.1186/s40880-016-0167-228031050
   PubMedGoogle Scholar
• JiGW, ZhangYD, ZhangH, et al. Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology. 2019;290(1):90–98. doi:10.1148/radiol.201818140830325283
   PubMed Web of Science ®Google Scholar
• WangY, LiuW, YuY, et al. CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer. Eur Radiol. 2020;30(2):976–986. doi:10.1007/s00330-019-06398-z31468157
   PubMed Web of Science ®Google Scholar
• BogowiczM, RiestererO, StarkLS, et al. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma. Acta Oncol. 2017;56(11):1531–1536. doi:10.1080/0284186X.2017.134638228820287
   PubMed Web of Science ®Google Scholar
• KangB, SunC, GuH, et al. T1 stage clear cell renal cell carcinoma: a CT-based radiomics nomogram to estimate the risk of recurrence and metastasis. Front Oncol. 2020;10:579619. doi:10.3389/fonc.2020.57961933251142
   PubMed Web of Science ®Google Scholar
• CozziL, FranzeseC, FogliataA, et al. Predicting survival and local control after radiochemotherapy in locally advanced head and neck cancer by means of computed tomography based radiomics. Strahlentherapie Und Onkologie. 2019;195(9):805–818. doi:10.1007/s00066-019-01483-031222468
   PubMed Web of Science ®Google Scholar
• ChenL, WangH, ZengH, et al. Evaluation of CT-based radiomics signature and nomogram as prognostic markers in patients with laryngeal squamous cell carcinoma. Cancer Imaging. 2020;20(1):28. doi:10.1186/s40644-020-00310-532321585
   PubMed Web of Science ®Google Scholar
• VasquezMM, HuC, RoeDJ, et al. Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med Res Methodol. 2016;16(1):154. doi:10.1186/s12874-016-0254-827842498
   PubMed Web of Science ®Google Scholar
• WuS, ZhengJ, LiY, et al. A radiomics nomogram for the preoperative prediction of lymph node metastasis in bladder cancer. Clin Cancer Res. 2017;23(22):6904–6911. doi:10.1158/1078-0432.CCR-17-151028874414
   PubMed Web of Science ®Google Scholar
• ZhouY, HeL, HuangY, et al. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma. Abdominal Radiol. 2017;42(6):1695–1704. doi:10.1007/s00261-017-1072-0
   PubMed Web of Science ®Google Scholar
• YuanC, WangZ, GuD, et al. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram. Cancer Imaging. 2019;19(1):21. doi:10.1186/s40644-019-0207-731027510
   PubMed Web of Science ®Google Scholar
• LvW, YuanQ, WangQ, et al. Radiomics analysis of PET and CT components of PET/CT imaging integrated with clinical parameters: application to prognosis for nasopharyngeal carcinoma. Mol Imaging Biol. 2019;21(5):954–964. doi:10.1007/s11307-018-01304-330671740
   PubMed Web of Science ®Google Scholar
• BogowiczM, VuongD, HuellnerMW, et al. CT radiomics and PET radiomics: ready for clinical implementation?Quart J Nucl Med Mol Imaging. 2019;63(4):355–370. doi:10.23736/S1824-4785.19.03192-3
   PubMed Web of Science ®Google Scholar
• WeiKR, ZhengRS, ZhangSW, et al. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36(1):90. doi:10.1186/s40880-017-0257-929122009
   PubMedGoogle Scholar
• DemeD, TelekesA. [Prognostic importance of lactate dehydrogenase (LDH) in oncology]. Orv Hetil. 2017;158(50):1977–1988. [Danish]. doi:10.1556/650.2017.3089029226713
   PubMed Web of Science ®Google Scholar
• YangQ, CaoSM, GuoL, et al. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial. Eur J Cancer. 2019;119:87–96. doi:10.1016/j.ejca.2019.07.00731425966
   PubMed Web of Science ®Google Scholar
• SunY, LiWF, ChenNY, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a Phase 3, multicentre, randomised controlled trial. Lancet Oncol. 2016;17(11):1509–1520. doi:10.1016/S1470-2045(16)30410-727686945
   PubMed Web of Science ®Google Scholar
• TanTH, SoonYY, CheoT, et al. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: a systematic review and meta-analysis. Radiother Oncol. 2018;129(1):10–17. doi:10.1016/j.radonc.2018.02.02729555182
   PubMed Web of Science ®Google Scholar
• ZengX, LiuG, PanY, et al. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma. J Cell Mol Med. 2020;24(15):8326–8349. doi:10.1111/jcmm.1509732603520
   PubMed Web of Science ®Google Scholar
• JiangY, QuS, PanX, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma. Oncotarget. 2018;9(11):9992–10004. doi:10.18632/oncotarget.2417329515785
   PubMedGoogle Scholar
• TopkanE, EkiciNY, OzdemirY, et al. Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy. Int J Biol Markers. 2019;34(2):139–147.30864463
   PubMed Web of Science ®Google Scholar
• ZengQ, ShenLJ, LiS, et al. The effects of hemoglobin levels and their interactions with cigarette smoking on survival in nasopharyngeal carcinoma patients. Cancer Med. 2016;5(5):816–826. doi:10.1002/cam4.64726817420
   PubMed Web of Science ®Google Scholar
• GaoJ, HuJY, XiaYF, et al. Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy. Chin J Cancer. 2010;29(5):561–566. doi:10.5732/cjc.009.1053320426909
   PubMedGoogle Scholar
• TempletonAJ, McNamaraMG, ŠerugaB, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. doi:10.1093/jnci/dju12424875653
   PubMedGoogle Scholar
• JanssensGO, RademakersSE, TerhaardCH, et al. Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer. Clin Cancer Res. 2014;20(5):1345–1354. doi:10.1158/1078-0432.CCR-13-173024452791
   PubMed Web of Science ®Google Scholar
• ZhangB, TianJ, DongD, et al. Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res. 2017;23(15):4259–4269. doi:10.1158/1078-0432.CCR-16-291028280088
   PubMed Web of Science ®Google Scholar
• ZhuC, HuangH, LiuX, et al. A clinical-radiomics nomogram based on computed tomography for predicting risk of local recurrence after radiotherapy in nasopharyngeal carcinoma. Front Oncol. 2021;11:637687. doi:10.3389/fonc.2021.63768733816279
   PubMed Web of Science ®Google Scholar
• NilssonJS, ForslundO, AnderssonFC, et al. Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer. Sci Rep. 2019;9(1):15432. doi:10.1038/s41598-019-51767-931659192
   PubMed Web of Science ®Google Scholar